LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Vivani Medical

Закрыт

1.14 0.88

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.12

Макс.

1.16

Ключевые показатели

By Trading Economics

Сотрудники

37

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+247.83% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

12 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.4M

62M

Предыдущая цена открытия

0.26

Предыдущая цена закрытия

1.14

Vivani Medical График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

2 сент. 2025 г., 23:07 UTC

Приобретения, слияния, поглощения

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 сент. 2025 г., 22:10 UTC

Главные движущие силы рынка

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 сент. 2025 г., 21:47 UTC

Отчет

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 сент. 2025 г., 16:52 UTC

Главные движущие силы рынка

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 сент. 2025 г., 22:47 UTC

Обсуждения рынка

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 сент. 2025 г., 21:40 UTC

Приобретения, слияния, поглощения

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 сент. 2025 г., 21:07 UTC

Отчет

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 сент. 2025 г., 21:07 UTC

Отчет

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 сент. 2025 г., 21:05 UTC

Отчет

Couche-Tard 1Q Rev $17.35B >ATD.T

2 сент. 2025 г., 21:05 UTC

Отчет

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 сент. 2025 г., 21:05 UTC

Отчет

Couche-Tard 1Q EPS 82c >ATD.T

2 сент. 2025 г., 21:05 UTC

Отчет

Couche-Tard 1Q Net $782.5M >ATD.T

2 сент. 2025 г., 21:00 UTC

Обсуждения рынка

ESG Roundup: Market Talk

2 сент. 2025 г., 20:53 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 сент. 2025 г., 20:51 UTC

Приобретения, слияния, поглощения

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

2 сент. 2025 г., 20:27 UTC

Отчет

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 сент. 2025 г., 20:24 UTC

Приобретения, слияния, поглощения

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 сент. 2025 г., 20:18 UTC

Приобретения, слияния, поглощения

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 сент. 2025 г., 20:17 UTC

Приобретения, слияния, поглощения

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 сент. 2025 г., 20:16 UTC

Приобретения, слияния, поглощения

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 сент. 2025 г., 20:16 UTC

Приобретения, слияния, поглощения

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 сент. 2025 г., 20:15 UTC

Приобретения, слияния, поглощения

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 сент. 2025 г., 19:55 UTC

Отчет

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 сент. 2025 г., 19:50 UTC

Приобретения, слияния, поглощения

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 сент. 2025 г., 19:09 UTC

Обсуждения рынка

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 сент. 2025 г., 19:00 UTC

Обсуждения рынка

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 сент. 2025 г., 18:12 UTC

Обсуждения рынка

Gold Pushes To New Record -- Market Talk

2 сент. 2025 г., 17:04 UTC

Обсуждения рынка

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 сент. 2025 г., 16:57 UTC

Приобретения, слияния, поглощения

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Vivani Medical Прогноз

Целевая цена

By TipRanks

247.83% рост

Прогноз на 12 месяцев

Средняя 4 USD  247.83%

Максимум 4 USD

Минимум 4 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Vivani Medical на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

2

Покупка

0

Удержание

0

Продажа

Финансовые показатели

$

О компании Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.